Financials data is unavailable for this security.
View more
Year on year Alto Neuroscience Inc 's net income fell 31.02% from a loss of 27.71m to a larger loss of 36.31m despite flat revenues.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, Alto Neuroscience Inc increased its cash reserves by 70.75%, or 34.20m. Cash Flow from Financing totalled 68.13m or -- of revenues. In addition the company used 33.45m for operations while cash used for investing totalled 470.00k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.67 |
---|---|
Tangible book value per share | 6.67 |
More ▼
Balance sheet in USDView more
Current ratio | 19.85 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.056 |
---|---|
Total debt/total capital | 0.053 |
More ▼